Afficher la couverture 'Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial | Naccache, Jean-Marc' en grand format
/5

0 avis

Suggestions

Du même auteur

French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis – 2021 update. Full-length version

Archive ouverte | Cottin, Vincent | CCSD

National audience. BACKGROUND: Since the previous French guidelines were published in 2017, substantial additional knowledge about idiopathic pulmonary fibrosis has accumulated.METHODS: Under the auspices of the Fre...

French practical guidelines for the diagnosis and management of IPF - 2021 update, full version. Recommandations pratiques pour le diagnostic et la prise en charge de la fibrose pulmonaire idiopathique – Actualisation 2021. Version intégrale

Archive ouverte | Cottin, Vincent | CCSD

National audience. BACKGROUND: Since the previous French guidelines were published in 2017, substantial additional knowledge about idiopathic pulmonary fibrosis has accumulated. METHODS: Under the auspices of the Fr...

Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial

Archive ouverte | Mankikian, Julie | CCSD

International audience. Background Standard of care for interstitial lung disease (ILD) with a nonspecific interstitial pneumonia (NSIP) pattern proposes mycophenolate mofetil (MMF) as one of the first step therapie...

Chargement des enrichissements...